Exclusive

Publication

Byline

Location

Madrigal expands MASH pipeline with siRNA therapies in $4.4 B deal

Singapore, Feb. 12 -- Madrigal Pharmaceuticals, Inc., a US-based biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), has ann... Read More


MakeO announces acquisition of Zenyum to build Asia's largest consumer dental tech platform

Singapore, Feb. 11 -- MakeO (parent company of the leading Indian clear aligner brand, Toothsi) has entered into a definitive agreement to acquire Zenyum, Southeast Asia's leading consumer dental comp... Read More


OneSource-Hikma partnership secures approval to commercialise generic version of Ozempic(R) in Saudi Arabia

Singapore, Feb. 11 -- India's OneSource Specialty Pharma has received Saudi Food and Drug Authority (SFDA) approval of its generic Ozempic(R) (semaglutide) in Saudi Arabia, clearing the path for comme... Read More


Takeda and Iambic ink $1.7 B deal to advance AI driven design of small molecules

Singapore, Feb. 11 -- Iambic, a US-based clinical-stage life science and technology company developing novel medicines using its artificial intelligence (AI)-driven discovery and development platform,... Read More


GCCL and Medicover announce strategic collaboration to strengthen multinational clinical trial services

Singapore, Feb. 11 -- South Korea-based GCCL Co., a data-driven clinical trial services provider, and Germany-based Medicover Integrated Clinical Services (MICS), part of Medicover, an international h... Read More


medisana strengthens home healthcare access in Malaysia and Brunei through strategic partnership with DKSH

Singapore, Feb. 11 -- Germany-based medisana, a trusted global brand in home health and wellness solutions, has announced a strategic partnership with DKSH Business Unit Healthcare to expand distribut... Read More


Zuellig Pharma acquires brands from Bayer to strengthen consumer healthcare portfolio

Singapore, Feb. 10 -- Singapore-headquartered Zuellig Pharma has acquired all rights, title, and interest in and to the Zam-Buk(R) and Vapex(R) consumer healthcare brands from Bayer Consumer Care AG f... Read More


Innovent inks $8.5 B deal with Eli Lilly for oncology and immunology based medicines

Singapore, Feb. 10 -- China-based Innovent Biologics, Inc. has announced a strategic collaboration with Eli Lilly and Company, in the US, to advance novel medicines in oncology and immunology. This ag... Read More


Japan's Saisei Ventures launches bridge-to-biotech venture creation initiative

Singapore, Feb. 10 -- Saisei Ventures, a pioneering investment firm focused on advancing Japanese biotechnology and therapeutic innovations globally, announced the launch of Bridge-to-Biotech, a new i... Read More


Korean startup Neurophet secures US FDA 510(k) clearance for neuroimaging analysis solution

Singapore, Feb. 9 -- South Korea-based startup Neurophet, an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, has announced that its software solution, Neurop... Read More